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Purpose:  Live Mycobacterium bovis Bacille Calmette-Guérin (BCG) has a suppressive effect on asthma, but its use in clinical practice may be limit-
ed due to adverse reactions. To develop a product that is effective for suppressing asthma with minimal adverse reactions, we investigated whether 
the heat-killed body or culture supernatants of mycobacteria could also prevent asthma development.  Methods:  Female BALB/c mice were treat-
ed with live BCG, the heat-killed body, or culture supernatants of BCG or Mycobacterium tuberculosis intraperitoneally, while sensitizing and provok-
ing with ovalbumin. Then they underwent a methacholine bronchoprovocation test, and the peribronchial inflammatory cell numbers and cytokine 
levels in splenocyte culture supernatants were assessed.  Results:  The airway sensitivity to methacholine decreased significantly after treatment 
with not only live BCG (30.8 versus 10.0 mg/mL, P<0.001) but also with the culture supernatant (BCG, 23.0 mg/mL, P<0.05; M. tuberculosis, 20.5 
mg/mL, P<0.05). In contrast, heat-killed mycobacteria did not effectively decrease airway sensitivity. The peribronchial eosinophil counts and the 
goblet cell proportions in total epithelial cells decreased significantly in most of the groups. The interferon-g/interleukin-5 ratios increased signifi-
cantly in most of the treatment groups except for the heat-killed groups, and were significantly related to airway sensitivity (r=0.312, P<0.01) and 
peribronchial eosinophil counts (r=-0.416, P<0.001). Interleukin-17A level was inversely related to airway sensitivity (r=-0.212, P<0.05) and was sig-
nificantly lower in the live BCG group than in the control (137±20 versus 308±57 pg/mL, P<0.05).  Conclusions:  BCG and mycobacteria culture su-
pernatants may effectively prevent the development of asthma associated with altered Th1/Th2 cytokines and interleukin-17A levels.
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INTRODUCTION
The so-called “hygiene/old friends hypothesis” states that an 
increase in the prevalence of asthma/allergy is related to dimin-
ished exposure to infections and certain relatively harmless en-
vironmental organisms or components that the immune sys-
tem has learned to tolerate.
1 In this context, our group
2 and oth-
er investigators
3-7 have shown that Mycobacterium bovis Bacille 
Calmette-Guérin (BCG) and other mycobacterial infections 
suppress airway hyperresponsiveness and eosinophilic inflam-
mation, likely through a T-helper 1 (Th1) or regulatory T cell 
(Treg) response. We also demonstrated that BCG vaccination 
has therapeutic effects on asthma in adult patients.
8 However, 
Shirtcliffe et al.
9 reported that repeated heat-killed BCG vacci-
nations had no beneficial effects, and they halted the trial early 
due to severe local reactions in asthma patients. Although the 
mycobacterial strains,
10 route of delivery,
11 and other factors 
might have affected the efficacy of the vaccinations, it is neces-
sary to develop an effective anti-asthmatic agent devoid of ad-
verse reactions.
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Mycobacterial components rather than whole mycobacteria 
may be more promising to avoid untoward vaccination effects. 
The recognition of mycobacterial components by Toll-like re-
ceptor (TLR) 2 associated with TLR1/TLR6 and TLR4 on den-
dritic cells has been implicated in mycobacteria-induced Th1/
Treg cell responses.
12 In fact, the mycobacterial cell wall lipogly-
cans lipoarabinomannan (LAM) and phosphatidylinositol 
mannan suppress airway eosinophilia in association with in-
creased interleukin (IL)-10 secretion by T cells.
13 In addition, 
mannose-capped LAM from BCG induced Th1 cells,
14 and that 
from M. tuberculosis induced Treg cells from human peripheral 
blood mononuclear cells.
15 Synthetic lipopeptides that stimu-
late TLR2 decrease airway eosinophilia and IgE levels but in-
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crease IL-10 and interferon (IFN)-g production by T cells.
16 My-
cobacterial chaperonin 60.1 also suppresses airway eosinophil-
ia and methacholine airway hypersensitivity.
17 However, only a 
few studies using mycobacterial components in vaccinations 
have investigated their effects on asthma, and no study has 
compared the efficacy of various mycobacterial strains. There-
fore, we investigated whether whole heat-killed mycobacteria 
and their products in the culture supernatants, from both M. 
tuberculosis and BCG, are effective for preventing the develop-
ment of asthma.
MATERIALS AND METHODS
Experimental animals
Specific pathogen-free, 6-week-old female BALB/c mice (Dae-
han BioLink, Eumsung, Korea) were fed standard mouse chow 
and given water ad libitum in an animal care room at Chonnam 
National University Medical School, Korea. Animal care and 
treatment followed the guidelines of the Chonnam National 
University Research Institute of Medical Sciences.
Study design
The mice were divided into 12 groups (n=10 per group): one 
normal control group, one asthma control group, four M. tuber-
culosis groups (heat-killed or culture supernatants), and six 
BCG groups (live, heat-killed, or culture supernatants; Fig. 1). 
On the first day of the study, the mice in the treatment groups 
were given 1×10
5 or 1×10
6 colony-forming units (CFUs) of my-
cobacteria, or 20 or 200 μg of culture supernatant intraperitone-
ally. Then, the mice were sensitized and provoked using ovalbu-
min, underwent a methacholine bronchial challenge test, and 
were sacrificed so that the inflammatory cell numbers in the 
peribronchial tissue and the cytokine levels in the supernatants 
of concanavalin A-stimulated splenocytes could be quantified.
Preparation of mycobacteria and culture supernatants
Pathogenic M. tuberculosis H37Rv (ATCC 27294) and M. bovis 
BCG Tokyo 172 strain (obtained from the Korean National Tu-
berculosis Association, Seoul) were cultured as surface pellicles 
on Sauton’s medium at 37°C. After 6 weeks, the bacilli were re-
moved by filtration through filter paper. The culture superna-
tants were sequentially sterilized using a membrane filter (1.2- 
and 0.2-μm pore size) and concentrated by ultrafiltration (Ami-
con Centriprep-10, Millipore, Bedford, MA, USA). The concen-
tration of culture filtrate antigen was determined using a bicin-
choninic acid protein assay kit (Pierce Biotechnology, Rock-
ford, IL, USA).
To prepare the live bacterial stock, both mycobacteria were 
grown in roller bottles containing Middlebrook 7H9 broth (Dif-
co, Detroit, MI, USA) supplemented with 0.05% Tween 80 and 
10% oleic acid-albumin-dextrose-catalase (Becton Dickinson, 
Cockeysville, MD, USA) at 37°C until the optical density at 600 
nm reached 0.8. The cells were washed three times with phos-
phate-buffered saline (PBS) and centrifuged at 150×g for 5 min-
utes to remove any clumps. Aliquots of the upper bacterial sus-
pension were kept at -80°C until use. The thawed bacterial ali-
quots used for infection were dispersed using a bath sonicator. 
The CFUs in the dispersed supernatants were determined by 
preparing serial dilutions in 7H9 broth and plating them onto 
Middlebrook 7H10 agar (Difco). To protect the laboratory work-
ers from mycobacterial infection, the M. tuberculosis inocu-
lums were prepared like those that were heated for 15 minutes. 
The culture supernatants, which contain most of the secreted 
antigens, were concentrated 10-fold for administration.
Ovalbumin sensitization and provocation
The animals were sensitized using two intraperitoneal injec-
tions of 200 μL PBS containing 20 μg ovalbumin (Grade V; Sig-
ma-Aldrich, St. Louis, MO, USA) and 2.25 mg aluminum hy-
droxide (Imject Alum; Pierce) 2 weeks apart. One week after 
the second sensitization injection, the mice were provoked with 
1% ovalbumin aerosol using an ultrasonic nebulizer (Ultra-
Neb; DeVilbiss, Somerset, PA, USA) in an animal body plethys-
mograph (OCP3000; All Medicus, Ahnyang, Korea) for 30 min-
utes per day for three successive days.
Lung function tests
Airway responsiveness to methacholine (Sigma) was mea-
sured using a OCP3000 body plethysmograph, as described 
previously.
10 Briefly, 24 hours after the final ovalbumin inhala-
tion challenge, the animals inhaled PBS aerosol and then in-
haled progressively doubled concentrations of methacholine, 
starting from 3.125 mg/mL and increasing to 50 mg/mL. Aero-
sols were generated using an Ultra-Neb nebulizer, and 3 mL of 
Groups
A. Normal
B. Asthma
C. HK M. tuberculosis  10
5 CFUs
D. HK M. tuberculosis  10
6 CFUs
E. Live BCG Tokyo 172  10
5 CFUs
F.  Live BCG Tokyo 172  10
6 CFUs
G. HK BCG Tokyo 172  10
5 CFUs
H. HK BCG Tokyo 172  10
6 CFUs
I.  Cul-S M. tuberculosis  20 µg
J. Cul-S M. tuberculosis  200 µg
K. Cul-S BCG Tokyo 172  20 µg
L.  Cul-S BCG Tokyo 172  200 µg
- Methacholine test
- Lung tissue examination
- Cytokines in splenocyte supernatant
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Fig. 1.  The time course of the experiment. OVA, ovalbumin; IP, intraperitoneal; 
M. tuberculosis, Mycobacterium tuberculosis; BCG, bacille Calmette-Guérin; 
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solution was aerosolized for 3 minutes. Enhanced pause (Penh) 
was used to represent airway resistance, as described previous-
ly.
10 The methacholine concentration required for a 200% in-
crease in Penh from the post-saline value (PC200) was obtained 
as an index of airway sensitivity.
Histological analysis
The left lung was fixed in 4% formalin and embedded in par-
affin for histopathological analysis. The embedded tissue was 
sectioned every 4 µm and stained with hematoxylin-eosin and 
periodic acid-Schiff. Small airways (circumference <500 μm) 
were selected,
18 and the numbers of eosinophils, lymphocytes, 
and neutrophils within the peribronchial area from the base-
ment membrane to a depth of 100 μm were determined and 
expressed as the number of cells/mm
2 using a Nikon micro-
scope with a computerized image analyzer program (AnalySIS
® 
Pro; Soft Imaging System GmBH, Münster, Germany).
19 Goblet 
cell hyperplasia was evaluated according to a 5-point scoring 
system (0-4), defined as follows: 0, no goblet cells; 1, <25%; 2, 
25-50%; 3, 50-75%; and 4, ≥75%.
20
Culture supernatant cytokine assays
Splenocyte culture and cytokine measurements were per-
formed as described previously.
10 Briefly, splenocytes were cul-
tured in RPMI 1640 (BioWhittaker, Walkersville, NY, USA) sup-
plemented with 10% fetal bovine serum (Gibco BRL, Grand Is-
land, NY, USA) and a 1% penicillin-streptomycin-amphotericin 
B mixture (BioWhittaker) and were stimulated with 2.5 μg/mL 
concanavalin A (Sigma) for 48 hours. The IFN-g, IL-5, and IL-
17A concentrations were determined in the supernatant of 
stimulated splenocytes using commercial enzyme-linked im-
munosorbent assay (ELISA) kits (BioLegend, Inc., San Diego, 
CA, USA). The sensitivities of the assays for IFN-g, IL-5, and IL-
17A were 4, 8, and 7.8 pg/mL, respectively.
Statistical analysis
The PC200 was Log10 transformed before analysis, and all sta-
tistical results are expressed as the mean±SEM. The Kruskal-
Wallis test and Mann-Whitney U-test were used to determine 
the significant differences between groups. Associations be-
tween variables were examined using Spearman’s rank correla-
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Fig. 2.  Dose response curves for methacholine (MCh) challenges. n=10 per 
group. Penh, enhanced pause; BCG, bacille Calmette-Guérin; TB, Mycobacterium 
tuberculosis; Cul-S, culture-supernatant. *P<0.05 and **P<0.01 for low dose 
treatments, and 
†P<0.05 and 
††P<0.01 for high dose treatments compared with 
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tion coefficient. A P value <0.05 was considered statistically sig-
nificant.
RESULTS
Airway responsiveness
The percent increases in Penh relative to baseline after metha-
choline inhalation were significantly higher in the asthma 
group than the normal control group at each concentration of 
methacholine (P<0.01; Fig. 2). Compared to the asthma group, 
the Penh values were significantly lower in response to 3.125, 
6.25, 12.5, and 25 mg/mL of methacholine in mice treated with 
1×10
5 CFUs of live BCG. Similarly, 1×10
6 CFUs of live BCG sig-
nificantly decreased the values obtained after 3.125, 6.25, and 
12.5 mg/mL methacholine treatment. Moreover, 20 μg BCG cul-
ture supernatant significantly decreased the Penh values at 3.125 
and 12.5 mg/mL methacholine treatment while 200 μg BCG 
culture supernatant decreased the value at 12.5 mg/mL metha-
choline treatment. Both 20 and 200 μg M. tuberculosis culture 
supernatant also significantly decreased the Penh values at 3.125 
and 12.5 mg/mL methacholine treatment. In addition, metha-
choline-PC200 was significantly higher in groups treated with 
live BCG (geometric mean, 30.8 versus 10.0 mg/mL, P<0.001) 
and groups treated with culture supernatant (BCG, 23.0 mg/
mL, P<0.05; M. tuberculosis, 20.5 mg/mL, P<0.05) than in the 
asthma control group (Fig. 3). However, the heat-killed BCG 
and M. tuberculosis mycobacteria did not significantly suppress 
airway responsiveness.
Inflammatory cells in peribronchial tissue and epithelial goblet 
cells
The asthma control group had significantly more peribron-
chial eosinophils than the normal control group (Fig. 4). All 
treatments except 1×10
6 CFUs of heat-killed M. tuberculosis and 
1×10
5 CFUs of heat-killed BCG significantly suppressed peri-
bronchial eosinophilia. The peribronchial neutrophil counts 
were also significantly higher in the asthma control group than 
in the normal control group (251±64 versus 57±19/mm
2, P<
0.01), and were lower in all of the treatment groups but only sig-
nificantly lower in those treated with 200 μg BCG (85±22/mm
2, 
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P<0.05) or M. tuberculosis (93±12/mm
2, P<0.05) culture super-
natant. Furthermore, the proportion of goblet cells in the epi-
thelial cells was significantly lower in all of the treated groups 
than in the asthma control group (Fig. 4).
Cytokine concentrations in the cultured splenocyte 
supernatants
In the supernatants of concanavalin A-stimulated spleno-
cytes, the IL-5 level was significantly higher, and the IFN-g con-
centration and the IFN-g/IL-5 ratio were significantly lower, in 
the asthma control group than in the normal control group (Fig. 
5). Compared to the asthma group, the IFN-g/IL-5 ratio was sig-
nificantly higher in all treated groups except those treated with 
heat-killed mycobacteria. The IL-17A level was significantly 
higher in the asthma control group than in the normal control 
group. Only the treatment with 1×10
5 CFUs of live BCG signifi-
cantly decreased IL-17A levels (137.1±20.5 versus 308.2±57.4 
pg/mL, P<0.05). The IFN-g/IL-5 ratio was significantly associat-
ed with airway sensitivity (P<0.01), the number of peribronchi-
al eosinophils (P<0.001), and goblet cell hyperplasia (P<0.001; 
Table 1). However, IL-17A level had a weak inverse relationship 
only with airway sensitivity (P<0.05).
DISCUSSION
Treatment of mice with live BCG significantly suppressed air-
way responsiveness, eosinophilia, and goblet cell hyperplasia. 
These results are consistent with those of previous studies show-
ing that BCG
2-4,6,10,11,21 and M. vaccae
6,18 have suppressive effects 
on asthma.
Furthermore, we found that the BCG and M. tuberculosis cul-
ture supernatants also effectively suppressed asthmatic reac-
tions, although the effectiveness for suppressing airway respon-
siveness was somewhat lower in the culture supernatant groups 
than in the live BCG group. Means et al.
22 demonstrated that M. 
tuberculosis culture media induce TLR2-dependent cellular ac-
tivation, and suggested that TLR2 ligand was the non-protein-
aceous heat-stable factor. Because TLR2 stimulation suppresses 
airway eosinophilia,
16 a soluble factor released by cultured my-
cobacteria might have acted as a TLR2 ligand in the present 
study.
We also found that vaccination with heat-killed mycobacteria 
was ineffective for airway responsiveness even though it signifi-
cantly suppressed airway eosinophilia and goblet cell hyper-
plasia. Major et al.
23 also showed that the efficacy of heat-killed 
BCG against the development of airway eosinophilia was lower 
than that of live BCG. The lower effectiveness of the culture su-
pernatants and heat-killed preparations used in this study may 
be explained at least in part as follows: a) live BCG may not only 
release an effective factor after inoculation, but it also has cell 
wall components such as LAM and phosphatidylinositol that 
increase IL-10 secretion;
13 b) the effects are dose-dependent
3 
and live BCG must work longer in vivo due to its proliferation 
potential; c) some components that actively suppress allergic 
responses are heat-labile. Means et al.
22 showed that a heat-
sensitive cell-associated mycobacterial factor distinct from LAM 
mediated TLR4-dependent activation. However, Zuany-Amor-
im et al.
7 demonstrated that treating mice with heat-killed M. 
vaccae induces allergen-specific Treg cells and effectively sup-
presses methacholine airway responsiveness and airway eosin-
ophilia. Therefore, if these less effective preparations are used 
instead of live mycobacteria as an asthma vaccine to avoid ad-
verse effects, there may be a need to increase the vaccine dose 
or manipulate the vaccine content to increase their efficacy.
IFN-g production induced by M. tuberculosis is 4-fold greater 
than that induced by BCG,
24 so we can speculate that M. tuber-
Table 1.  Relationship between levels of cytokines in splenocyte supernatants 
and markers of asthmatic airway reactions in mice
IL-5 IFN-g IFN-g/IL-5 IL-17A
PC200 (mg/mL) -0.303** 0.149 0.312** -0.212*
Peribronchial Eos (/mm
2) 0.416*** -0.237** -0.416*** 0.051
Peribronchial Neut (/mm
2) 0.152 -0.207* -0.214* 0.069
Goblet cell grade
† 0.449*** -0.321*** -0.473*** 0.074
IL, interleukin; IFN, interferon; PC200, the concentration of methacholine re-
quired for a 200% increase of lung function measurement from baseline; Eos, 
eosinophils; Neut, neutrophils. 
†, the proportion of the goblet cells in the epithe-
lial cells; 0, no goblet cells; 1, <25%; 2, 25-50%; 3, 50-75%; 4, ≥75%. *P<0.05, 
**P<0.01 and ***P<0.001.
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* * *
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*
16
14
12
10
8
6
4
2
0
I
F
N
-
g
/
I
L
-
5
 
r
a
t
i
o
Normal
Asthma
HK TB 10(5)
HK TB 10(6)
Live BCG 10(5)
Live BCG 10(6)
HK BCG 10(5)
HK BCG 10(6)
Cul-S TB 20 µg
Cul-S TB 200 µg
Cul-S BCG 20 µg
Cul-S BCG 200 µg
Fig. 5.  Comparisons of the interferon (IFN)-g/interleukin (IL)-5 ratios in the su-
pernatants of concanavalin A-stimulated splenocytes. n=10 per group. TB, My-
cobacterium tuberculosis; BCG, bacille Calmette-Guérin; HK, heat-killed; Cul-S, 
culture-supernatant. *P<0.05, **P<0.01, and ***P<0.05 compared with the 
asthma control.Allergy Asthma Immunol Res. 2010 January;2(1):34-40.  doi: 10.4168/aair.2010.2.1.34
Preventive effect of mycobacteria against asthma AAIR 
39 http://e-aair.org
culosis culture supernatants or heat-killed preparations would 
be more effective for suppressing asthmatic reactions than 
those of BCG. However, this was not the case in the present 
study, and there were no differences between them. A large ep-
idemiological study by von Mutius et al.
25 showed that an in-
crease in the tuberculosis notification rates of 25 per 100,000 
was associated with a decrease in the prevalence of asthma by 
4.7%, while another large epidemiological study by Grüber et 
al.
26 reported that BCG vaccination had only a weak protective 
effect against asthma. Thus, the difference in IFN-g levels be-
tween BCG and M. tuberculosis and its effect on asthma may be 
related to any difference in a heat-sensitive cell-associated my-
cobacterial factor. Further studies are needed to investigate this 
possibility.
The effects of the mycobacteria treatments, including the my-
cobacteria culture supernatants, on asthmatic reactions were 
associated with increases in the IFN-g/IL-5 ratio. These results 
are consistent with those of previous studies showing that my-
cobacterial infections
2-6,10,11,21 or administering mycobacterial 
components
17 shift the Th1/Th2 balance toward Th1. IFN-g 
seems to play a key role in the mycobacterial effects on Th2 cy-
tokines and airway eosinophilia, because these effects are 
strongly impaired in IFN-g-deficient mice.
23 In addition, provo-
cation via allergen inhalation induces IL-17 mRNA expression 
and neutrophilic influx in the airways of mice.
27 Recently, 
McKinley et al.
28 showed that transferring Th17 cells that pro-
duce IL-17 into mice results in neutrophilic airway inflamma-
tion and methacholine airway hyperresponsiveness. Therefore, 
the inverse relationship between PC200 and IL-17A in the pres-
ent study may be attributable to neutrophils despite the lack of 
a significant relationship between IL-17A and neutrophils. 
However, IL-17 decreases airway eosinophilia
27 and may re-
duce matrix deposition by inducing metalloproteinases.
29 The 
complex action of IL-17 on asthma needs further investigation.
Because the airway cytokines and the ovalbumin-specific cy-
tokines in the splenocyte culture supernatants were almost un-
detectable in a preliminary study, we did not check them in the 
present study. Future studies should consider airway cytokine 
profiles, especially for allergen-specific cytokines, using other 
methods such as Western blotting. Furthermore, lung function 
measurements should be validated using more rigorous meth-
ods, even though several previous studies used Penh values as an 
airway hyperresponsiveness measure.
Taken together, our results show that both live BCG and my-
cobacteria culture supernatants are effective for suppressing 
the development of asthmatic reactions. Therefore, the use of 
soluble culture supernatant components is promising for the 
development of asthma treatments without the adverse effects 
associated with whole live BCG. Heat-killed preparations were 
also effective for suppressing airway eosinophilia and remodel-
ing. However, the loss of an effect on airway hyperresponsive-
ness suggests that further studies of mycobacterial cell wall 
components are needed to develop more effective vaccines to 
treat asthma. Finally, the effects of mycobacteria and their com-
ponents were associated with altered levels of Th1/Th2 cyto-
kines and interleukin-17A.
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